Skip to main content

Table 1 Percentage of cell types on day 8 as presented in Fig. 5, calculated as mean ± SEM (n = 3) for all mouse groups: 70Z/3-L parent, naïve, LV15Rc.4, and LV15sol.1

From: Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model

Cell population

70Z/3 parent

naive

LV15Rc.4

LV15sol.1

GFP+ leukemia cells

84.84 ± 2.5%

n/a

6.19 ± 1.42

10.91 ± 1.7%

CD4+

1.44 ± 0.09%

1.74 ± 0.58%

2.33 ± 0.68%

9.72 ± 0.51

CD8+

0.47 ± 0.14%

1.11 ± 0.13

8.08 ± 1.87%

18.07 ± 1.9%

NK1.1+

4.3 ± 2.54%

2.57 ± 0.73

47.62 ± 4.96%

7.68 ± 0.57%

‘other’

8.96 ± 2.7%

94.57 ± 1.12

35.77 ± 5.86%

53.62 ± 1.85%